Biggest changeYears Ended December 31, 2022 2021 Increase (Decrease) (Dollars in millions) Revenues Sales and other operating revenue $ 1,972.5 $ 1,456.0 $ 516.5 Costs and operating expenses Cost of products sold and operating expenses 1,604.9 1,118.8 486.1 Selling, general and administrative expenses 71.4 61.8 9.6 Depreciation and amortization expense 142.5 133.9 8.6 Total costs and operating expenses 1,818.8 1,314.5 504.3 Operating income 153.7 141.5 12.2 Interest expense, net 32.0 42.5 (10.5) Loss on extinguishment of debt — 31.9 (31.9) Income before income tax expense 121.7 67.1 54.6 Income tax expense 16.8 18.3 (1.5) Net income 104.9 48.8 56.1 Less: Net income attributable to noncontrolling interests 4.2 5.4 (1.2) Net income attributable to SunCoke Energy, Inc. $ 100.7 $ 43.4 $ 57.3 Sales and Other Operating Revenue and Costs of Products Sold and Operating Expenses.
Biggest changeRefer to Management's Discussion and Analysis of Financial Condition and Results of Operations in our 2022 Annual Report on Form 10-K for the year-over-year analysis of consolidated results of operations for the year ended December 31, 2022 as compared to the year ended December 31, 2021. 32 Table of Contents Years Ended December 31, 2023 2022 Increase (Decrease) (Dollars in millions) Revenues Sales and other operating revenue $ 2,063.2 $ 1,972.5 $ 90.7 Costs and operating expenses Cost of products sold and operating expenses 1,724.6 1,604.9 119.7 Selling, general and administrative expenses 70.7 71.4 (0.7) Depreciation and amortization expense 142.8 142.5 0.3 Total costs and operating expenses 1,938.1 1,818.8 119.3 Operating income 125.1 153.7 (28.6) Interest expense, net 27.3 32.0 (4.7) Income before income tax expense 97.8 121.7 (23.9) Income tax expense 34.3 16.8 17.5 Net income 63.5 104.9 (41.4) Less: Net income attributable to noncontrolling interests 6.0 4.2 1.8 Net income attributable to SunCoke Energy, Inc. $ 57.5 $ 100.7 $ (43.2) Sales and Other Operating Revenue and Costs of Products Sold and Operating Expenses.
Critical Accounting Policies and Estimates A summary of our significant accounting policies is included in Note 2 to the consolidated financial statements. Our management believes that the application of these policies on a consistent basis enables us to provide the users of our financial statements with useful and reliable information about our operating results and financial condition.
Critical Accounting Policies and Estimates A summary of our significant accounting policies is included in Note 2 to our consolidated financial statements. Our management believes that the application of these policies on a consistent basis enables us to provide the users of our financial statements with useful and reliable information about our operating results and financial condition.
Ongoing capital expenditures do not include normal repairs and maintenance expenses, which are expensed as incurred; 38 Table of Contents • Expansion capital expenditures to acquire and/or construct complementary assets to grow our business and to expand existing facilities as well as capital expenditures made to enable the renewal of a coke sales agreement and/or logistics service agreement and on which we expect to earn a reasonable return; and • Environmental remediation project expenditures required to implement design changes to ensure that our existing facilities operate in accordance with existing environmental permits.
Ongoing capital expenditures do not include normal repairs and maintenance expenses, which are expensed as incurred; • Expansion capital expenditures to acquire and/or construct complementary assets to grow our business and to expand existing facilities as well as capital expenditures made to enable the renewal of a coke sales agreement and/or logistics service agreement and on which we expect to earn a reasonable return; and • Environmental remediation project expenditures required to implement design changes to ensure that our existing facilities operate in accordance with existing environmental permits.
As a result, our future results and financial condition may differ materially from those we currently anticipate as a result of the factors we describe under “Cautionary Statement Concerning Forward-Looking Statements” and “Risk Factors.” This Management’s Discussion and Analysis of Financial Condition and Results of Operations ("MD&A") is based on financial data derived from the financial statements prepared in accordance with United States generally accepted accounting principles (“GAAP”) and certain other financial data that is prepared using a non-GAAP measure.
As a result, our future results and financial condition may differ materially from those we currently anticipate as a result of the factors we describe under “Cautionary Statement Concerning Forward-Looking Statements” and “Risk Factors.” This Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) is based on financial data derived from the financial statements prepared in accordance with United States generally accepted accounting principles (“GAAP”) and certain other financial data that is prepared using a non-GAAP measure.
Non-GAAP Financial Measures In addition to the GAAP results provided in the Annual Report on Form 10-K, we have provided a non-GAAP financial measure, Adjusted EBITDA. Our management, as well as certain investors, uses this non-GAAP measure to analyze our current and expected future financial performance.
Non-GAAP Financial Measures In addition to the GAAP results provided in this Annual Report on Form 10-K, we have provided a non-GAAP financial measure, Adjusted EBITDA. Our management, as well as certain investors, use this non-GAAP measure to analyze our current and expected future financial performance.
The preparation of our consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and the disclosures of contingent assets and liabilities. The Company's black lung benefit obligations is an item that is subject to such estimates and assumptions.
The preparation 39 Table of Contents of our consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and the disclosures of contingent assets and liabilities. The Company's black lung benefit obligations is an item that is subject to such estimates and assumptions.
Net i ncome attributable to noncontrolling interest represents a 14.8 percent third-party interest in our Indiana Harbor cokemaking facility and fluctuates with the financial performance of that facility. 33 Table of Contents Results of Reportable Business Segments We report our business results through three segments: • Domestic Coke consists of our Jewell facility, located in Vansant, Virginia, our Indiana Harbor facility, located in East Chicago, Indiana, our Haverhill facility, located in Franklin Furnace, Ohio, our Granite City facility located in Granite City, Illinois, and our Middletown facility located in Middletown, Ohio. • Brazil Coke consists of operations in Vitória, Brazil, where we operate the ArcelorMittal Brazil cokemaking facility. • Logistics consists of Convent Marine Terminal ("CMT"), located in Convent, Louisiana, Kanawha River Terminal ("KRT"), located in Ceredo and Belle, West Virginia, SunCoke Lake Terminal ("Lake Terminal"), located in East Chicago, Indiana, and Dismal River Terminal ("DRT"), located in Vansant, Virginia.
Net i ncome attributable to noncontrolling interests represents a 14.8 percent third-party interest in our Indiana Harbor cokemaking facility and fluctuates with the financial performance of that facility. 33 Table of Contents Results of Reportable Business Segments We report our business results through three reportable segments: • Domestic Coke consists of our Jewell facility, located in Vansant, Virginia, our Indiana Harbor facility, located in East Chicago, Indiana, our Haverhill facility, located in Franklin Furnace, Ohio, our Granite City facility located in Granite City, Illinois, and our Middletown facility located in Middletown, Ohio. • Brazil Coke consists of operations in Vitória, Brazil, where we operate the ArcelorMittal Brazil cokemaking facility. • Logistics consists of CMT, located in Convent, Louisiana, KRT, located in Ceredo and Belle, West Virginia, and Lake Terminal, located in East Chicago, Indiana.
Liquidity and Capital Resources Our primary liquidity needs are to fund working capital, fund investments, service our debt, maintain cash reserves and replace partially or fully depreciated assets and other capital expenditures. Our sources of liquidity include cash generated from operations, borrowings under our Revolving Facility and, from time to time, debt and equity offerings.
Steel. Liquidity and Capital Resources Our primary liquidity needs are to fund working capital, fund investments, service our debt, maintain cash reserves and replace partially or fully depreciated assets and other capital expenditures. Our sources of liquidity include cash generated from operations, borrowings under our revolving credit facility (“Revolving Facility”) and, from time to time, debt and equity offerings.
We will submit comments on this proposed rule and continue to monitor any impact to the Company. See further discussion in Note 12 to our consolidated financial statements.
We submitted comments on this proposed rule and continue to monitor any impact to the Company. See further discussion in Note 12 to our consolidated financial statements.
For a reconciliation of the non-GAAP measure to its most comparable GAAP component, see "Non-GAAP Financial Measures" in this Item and Note 19 to our consolidated financial statements. Our MD&A is provided in addition to the accompanying consolidated financial statements and notes to assist readers in understanding our results of operations, financial condition and cash flows.
For a reconciliation of the non-GAAP measure to its most comparable GAAP component, see “Non-GAAP Financial Measures” in this Item 7. Our MD&A is provided in addition to the accompanying consolidated financial statements and notes to assist readers in understanding our results of operations, financial condition and cash flows.
We returned meaningful capital to our shareholders through the declaration and payment of a dividend during each quarter of 2022, increasing from $0.06 per share during the first half of the year to $0.08 per share during the second half of the year, representing a quarterly increase of 33 percent.
We returned meaningful capital to our shareholders through the declaration and payment of a dividend during each quarter of 2023, increasing from $0.08 per share during the first half of the year to $0.10 per share during the second half of the year, representing a quarterly increase of 25 percent.
(2) The production of foundry coke tons does not replace blast furnace coke tons on a ton for ton basis, as foundry coke requires longer coking time. The Domestic Coke capacity utilization is calculated assuming a single ton of foundry coke replaces approximately two tons of blast furnace coke.
(2) Corporate and Other, net is not a reportable segment. (3) The production of foundry coke tons does not replace blast furnace coke tons on a ton for ton basis, as foundry coke requires longer coking time. The Domestic Coke capacity utilization is calculated assuming a single ton of foundry coke replaces approximately two tons of blast furnace coke.
The following table summarizes our capital expenditures: Years Ended December 31, 2022 2021 (Dollars in millions) Ongoing capital $ 72.1 $ 87.6 Expansion capital (1) 3.4 11.0 Total capital expenditures (2) $ 75.5 $ 98.6 (1) Includes capital spending in connection with the foundry cokemaking growth project. (2) Reflects actual cash payments during the periods presented for our capital requirements.
The following table summarizes our capital expenditures: Years Ended December 31, 2023 2022 (Dollars in millions) Ongoing capital $ 94.5 $ 72.1 Expansion capital (1) 14.7 3.4 Total capital expenditures (2) $ 109.2 $ 75.5 (1) Includes capital spending in connection with the foundry cokemaking growth project. (2) Reflects actual cash payments during the periods presented for our capital requirements.
Management believes Adjusted EBITDA is an important measure of operating performance and uses it as the primary basis for the chief operating decision maker to evaluate the performance of each of our reportable segments. Adjusted EBITDA should not be considered a substitute for the reported results prepared in accordance with GAAP.
Management believes Adjusted EBITDA is an important measure of operating performance, which is used by the chief operating decision maker as one of the measurements to evaluate the performance of each of our reportable segments. Adjusted EBITDA should not be considered a substitute for the reported results prepared in accordance with GAAP.
Our results of operations include reference to our business operations and market conditions, which are further described in Part I of this document. 2022 Overview Our consolidated results of operations in 2022 were as follows: Year Ended December 31, 2022 (Dollars in millions) Net income $ 104.9 Net cash provided by operating activities $ 208.9 Adjusted EBITDA (1) $ 297.7 (1) See Note 19 in our consolidated financial statements for both the definition of Adjusted EBITDA and the reconciliation from GAAP to the non-GAAP measurement.
Our results of operations include reference to our business operations and market conditions, which are further described in Part I of this document. 2023 Overview Our consolidated results of operations in 2023 were as follows: Year Ended December 31, 2023 (Dollars in millions) Net income $ 63.5 Net cash provided by operating activities $ 249.0 Adjusted EBITDA (1) $ 268.8 (1) See “Non-GAAP Financial Measures” in this Item 7 below for both the definition of Adjusted EBITDA and the reconciliation from GAAP to the non-GAAP measurement.
(2) The current portion of the black lung liability was $5.9 million and $5.4 million at December 31, 2022 and 2021, respectively, and was included in accrued liabilities on the Consolidated Balance Sheets. 39 Table of Contents The following table summarizes annual black lung payments and (benefit) expense: Years Ended December 31, 2022 2021 2020 (Dollars in millions) Payments $ 5.0 $ 4.4 $ 6.0 (Benefit) expense (1) $ (0.2) $ 3.1 $ 15.4 (1) Black lung (benefit) expense incurred in excess of annual accretion of the black lung liability reflects the impact of changes in discount rates, current filing and approval rate assumptions and/or other changes in our actuarial assumptions.
The following table summarizes the annual black lung payments and expense (benefit): Years Ended December 31, 2023 2022 2021 (Dollars in millions) Payments $ 5.4 $ 5.0 $ 4.4 Expense (benefit) (1) $ 5.5 $ (0.2) $ 3.1 (1) Black lung expense (benefit) incurred in excess of annual accretion of the black lung liability reflects the impact of changes in discount rates, current filing and approval rate assumptions and/or other changes in our actuarial assumptions.
Black Lung Benefit Liabilities The Company has obligations related to coal workers’ pneumoconiosis, or black lung, to provide benefits to certain of its former coal miners and their dependents further described in Note 12 to our consolidated financial statements.
Black Lung Benefit Liabilities The Company has obligations related to coal workers’ pneumoconiosis, or black lung, to provide benefits to certain of its former coal miners and their dependents further described in Note 12 to our consolidated financial statements. We adjust our liability each year based upon actuarial calculations of our expected future payments for these benefits.
Cash Flow Summary The following table sets forth a summary of the net cash provided by (used in) operating, investing and financing activities for the years ended December 31, 2022 and 2021: Years Ended December 31, 2022 2021 (Dollars in millions) Net cash provided by operating activities $ 208.9 $ 233.1 Net cash used in investing activities (70.2) (99.3) Net cash used in financing activities (112.5) (118.4) Net increase in cash and cash equivalents $ 26.2 $ 15.4 Cash Provided by Operating Activities Net cash provided by operating activities decreased by $24.2 million to $208.9 million in 2022 as compared to 2021.
Cash Flow Summary The following table sets forth a summary of the net cash provided by (used in) operating, investing and financing activities for the years ended December 31, 2023 and 2022: Years Ended December 31, 2023 2022 (Dollars in millions) Net cash provided by operating activities $ 249.0 $ 208.9 Net cash used in investing activities (109.2) (70.2) Net cash used in financing activities (89.7) (112.5) Net increase in cash and cash equivalents $ 50.1 $ 26.2 Cash Provided by Operating Activities Net cash provided by operating activities increased $40.1 million to $249.0 million in 2023 as compared to 2022.
The following table summarizes discount rates utilized, active claims and the total black lung liabilities: December 31, 2022 2021 Discount rate (1) 4.9 % 2.4 % Active claims 332 332 Total black lung liability (dollars in millions) (2) $ 58.1 $ 63.3 (1) The discount rate is determined based on a portfolio of high-quality corporate bonds with maturities that are consistent with the estimated duration of our black lung obligations.
December 31, 2023 2022 (Dollars in millions) Discount rate (1) 4.5 % 4.9 % Active claims 311 332 Total black lung liability, discounted (2) $ 58.2 $ 58.1 Total black lung liability, undiscounted $ 96.0 $ 88.4 (1) The discount rate is determined based on a portfolio of high-quality corporate bonds with maturities that are consistent with the estimated duration of our black lung obligations.
The estimated liability may be impacted by future changes in the statutory mechanisms, modifications by court decisions and changes in filing patterns by claimants and their advisors, the impact of which cannot be estimated.
The estimated liability may be impacted by future changes in the statutory mechanisms, modifications by court decisions and changes in filing patterns by claimants and their advisors, the impact of which cannot be estimated. The following table summarizes discount rates utilized, active claims and the total black lung liabilities.
The decrease primarily reflects unfavorable year-over-year changes in primary working capital, which is comprised of accounts receivable, inventories and accounts payable, driven by higher coal prices.
The increase primarily reflects a favorable year-over-year change in primary working capital, which is comprised of accounts receivable, inventories, and accounts payable, driven by the timing of receipts from customers and the impact of the changes in coal prices.
See Note 19 to our consolidated financial statements. 34 Table of Contents Segment Operating Data The following table sets forth financial and operating data by segment for the years ended December 31, 2022 and 2021: Years Ended December 31, 2022 2021 Increase (Decrease) (Dollars in millions, except per ton amounts) Sales and other operating revenue: Domestic Coke $ 1,856.9 $ 1,354.5 $ 502.4 Brazil Coke 38.0 36.6 1.4 Logistics 77.6 64.9 12.7 Logistics intersegment sales 28.9 27.1 1.8 Elimination of intersegment sales (28.9) (27.1) (1.8) Total sales and other operating revenue $ 1,972.5 $ 1,456.0 $ 516.5 Adjusted EBITDA (1) : Domestic Coke $ 263.4 $ 243.4 $ 20.0 Brazil Coke 14.5 17.2 (2.7) Logistics 49.7 43.5 6.2 Corporate and Other, net (29.9) (28.7) (1.2) Total Adjusted EBITDA $ 297.7 $ 275.4 $ 22.3 Coke Operating Data: Domestic Coke capacity utilization (2) 100 % 101 % (1) % Domestic Coke production volumes (thousands of tons) 4,023 4,162 (139) Domestic Coke sales volumes (thousands of tons) 4,031 4,183 (152) Domestic Coke Adjusted EBITDA per ton (3) $ 65.34 $ 58.19 $ 7.15 Brazilian Coke production—operated facility (thousands of tons) 1,585 1,685 (100) Logistics Operating Data: Tons handled (thousands of tons) 22,291 19,933 2,358 (1) See Note 19 in our consolidated financial statements for both the definition of Adjusted EBITDA and the reconciliation from GAAP to the non-GAAP measurement.
See the “Non-GAAP Financial Measures” section below for both the definition of Adjusted EBITDA and the reconciliation from GAAP to the non-GAAP measurement. 34 Table of Contents Segment Operating Data The following table sets forth financial and operating data by segment for the years ended December 31, 2023 and 2022: Years Ended December 31, 2023 2022 Increase (Decrease) (Dollars in millions, except per ton amounts) Sales and other operating revenue: Domestic Coke $ 1,954.0 $ 1,856.9 $ 97.1 Brazil Coke 35.2 38.0 (2.8) Logistics 74.0 77.6 (3.6) Logistics intersegment sales 22.1 28.9 (6.8) Elimination of intersegment sales (22.1) (28.9) 6.8 Total sales and other operating revenue $ 2,063.2 $ 1,972.5 $ 90.7 Adjusted EBITDA (1) : Domestic Coke $ 247.8 $ 263.4 $ (15.6) Brazil Coke 9.1 14.5 (5.4) Logistics 44.3 49.7 (5.4) Corporate and Other, net (2) (32.4) (29.9) (2.5) Total Adjusted EBITDA $ 268.8 $ 297.7 $ (28.9) Coke Operating Data: Domestic Coke capacity utilization (3) 101 % 100 % 1 % Domestic Coke production volumes (thousands of tons) 4,049 4,023 26 Domestic Coke sales volumes (thousands of tons) 4,046 4,031 15 Domestic Coke Adjusted EBITDA per ton (4) $ 61.25 $ 65.34 $ (4.09) Brazilian Coke production—operated facility (thousands of tons) 1,558 1,585 (27) Logistics Operating Data: Tons handled (thousands of tons) 20,483 22,291 (1,808) (1) See the “Non-GAAP Financial Measures” section below for both the definition of Adjusted EBITDA and the reconciliation from GAAP to the non-GAAP measurement.
Dividends In addition to the $23.6 million in dividends paid to our shareholders during 2022, on February 2, 2023, SunCoke's Board of Directors declared a cash dividend of $0.08 per share of the Company's common stock. This dividend will be paid on March 1, 2023, to stockholders of record of February 16, 2023. See further discussion in "Item 5.
Dividends In addition to the $30.7 million in dividends paid to our shareholders during 2023, on February 1, 2024, SunCoke's Board of Directors declared a cash dividend of $0.10 per share of the Company's common stock. This dividend will be paid 38 Table of Contents on March 1, 2024, to stockholders of record on February 15, 2024.
Contractual Obligations As of December 31, 2022, significant contractual obligations related to our metallurgical coal procurement contracts, which are generally based on annual coke production requirements at fixed coal prices, were $1,092.8 million and extend through 2023.
In November 2023, Moody’s Investors Service reaffirmed our corporate credit rating of B1 (positive). Contractual Obligations As of December 31, 2023, significant contractual obligations related to our metallurgical coal procurement contracts, which are generally based on annual coke production requirements at fixed coal prices, were $928.6 million and extend through 2024.
The increase was driven by higher employee related expenses and higher cost of professional services. These increased costs were mostly offset by valuation adjustments as a result of changes in discount rates on certain legacy liabilities, which decreased legacy costs by $3.3 million.
This decrease was primarily driven by valuation adjustments as a result of changes in discount rates on certain legacy liabilities, which increased legacy costs by $5.7 million, partially offset by lower employee related expenses and lower cost of professional services in the current year period.
These higher costs were partially offset by valuation adjustments as a result of changes in discount rates on certain legacy liabilities, which decreased legacy costs by $3.3 million as compared to the prior year. Depreciation and Amortization Expense. Depreciation and amortization expense increased as a result of depreciable assets placed into service since the prior year period.
These lower costs were partially offset by valuation adjustments primarily as a result of changes in discount rates on certain legacy liabilities, which increased legacy costs by $5.7 million as compared to the prior year. Depreciation and Amortization Expense. Depreciation and amortization expense was reasonably consistent with the prior year period. Interest Expense, net.
(3) Reflects Domestic Coke Adjusted EBITDA divided by Domestic Coke sales volumes. 35 Table of Contents Analysis of Segment Results Domestic Coke The following table explains year-over-year changes in our Domestic Coke segment's sales and other operating revenues and Adjusted EBITDA results: Sales and other operating revenue Adjusted EBITDA 2022 vs 2021 2022 vs 2021 (Dollars in millions) Beginning $ 1,354.5 $ 243.4 Volume (1) (46.4) (13.9) Price (2) 543.2 47.4 Operating and maintenance costs (3) N/A (13.1) Energy and other (4) 5.6 (0.4) Ending $ 1,856.9 $ 263.4 (1) Volumes decreased during 2022 primarily due to changes in the mix of production.
(4) Reflects Domestic Coke Adjusted EBITDA divided by Domestic Coke sales volumes. 35 Table of Contents Analysis of Segment Results Domestic Coke The following table explains year-over-year changes in our Domestic Coke segment's sales and other operating revenues and Adjusted EBITDA results: Sales and other operating revenue Adjusted EBITDA 2023 vs 2022 2023 vs 2022 (Dollars in millions) Beginning $ 1,856.9 $ 263.4 Volume (1) 3.9 0.8 Price (2) 103.3 (8.7) Operating and maintenance costs N/A (0.1) Energy and other (3) (10.1) (7.6) Ending $ 1,954.0 $ 247.8 (1) Higher volumes on our long-term, take-or-pay agreements increased both revenues and Adjusted EBITDA during 2023.
Sales and other operating revenue and costs of products sold and operating expenses increased in 2022 as compared to 2021, primarily driven by the pass-through of higher coal prices in our Domestic Coke segment, which also resulted in lower margins.
Sales and other operating revenue and costs of products sold and operating expenses increased in 2023 as compared to 2022, primarily driven by the pass-through of higher coal prices in our Domestic Coke segment. Additionally, revenues further benefited from higher volumes on our long-term, take-or-pay agreements.
We believe our current resources are sufficient to meet our working capital requirements for our current business for at least the next 12 months and thereafter for the foreseeable future. As of December 31, 2022, we had $90.0 million of cash and cash equivalents and $315.0 million of borrowing availability under our Revolving Facility.
We believe our current resources are sufficient to meet our working capital requirements for our current business for at least the next 12 months and thereafter for the foreseeable future.
The level of future capital expenditures will depend on various factors, including market conditions and customer requirements, and may differ from current or anticipated levels. Material changes in capital expenditure levels may impact financial results, including but not limited to the amount of depreciation, interest expense and repair and maintenance expense.
Material changes in capital expenditure levels may impact financial results, including but not limited to the amount of depreciation, interest expense and repair and maintenance expense.
This measure is not in accordance with, or a substitute for, GAAP and may be different from, or inconsistent with, non-GAAP financial measures used by other companies. See Note 19 in our consolidated financial statements for both the definition of Adjusted EBITDA and the reconciliation from GAAP to the non-GAAP measurement for 2022, 2021 and 2020.
This measure is not in accordance with, or a substitute for, GAAP and may be different from, or inconsistent with, non-GAAP financial measures used by other companies.
The amounts involved may be material. Refer to further liquidity discussion below as well as "Part II - Item 5 - Market for Registrant's Common Equity, Related Stockholders Matters and Issuer Purchases of Equity Securities." During the first quarter of 2020, the U.S.
Such repurchases or exchanges, if any, will depend on prevailing market conditions, our liquidity requirements, contractual restrictions and other factors. The amounts involved may be material. Refer to further liquidity discussion in “Part II - Item 5 - Market for Registrant's Common Equity, Related Stockholders Matters and Issuer Purchases of Equity Securities.” During the first quarter of 2020, the U.S.
Logistics The following table explains year-over-year changes in our Logistics segment's sales and other operating revenues and Adjusted EBITDA results: Sales and other operating revenue, inclusive of intersegment sales Adjusted EBITDA 2022 vs 2021 2022 vs 2021 (Dollars in millions) Beginning $ 92.0 $ 43.5 Transloading volumes (1) 5.9 3.6 Price/margin impact of mix in transloading services (2) 8.9 8.9 Other (3) (0.3) (6.3) Ending $ 106.5 $ 49.7 (1) Volumes improved as a result of increased demand driven by the strong domestic metallurgical and thermal coal markets.
Logistics The following table explains year-over-year changes in our Logistics segment's sales and other operating revenues, exclusive of intersegment sales, and Adjusted EBITDA results: Sales and other operating revenue, exclusive of intersegment sales Adjusted EBITDA 2023 vs 2022 2023 vs 2022 (Dollars in millions) Beginning $ 77.6 $ 49.7 Transloading volumes (1) (3.3) (13.3) Price/margin impact of mix in transloading services (2) 2.2 3.0 Other (3) (2.5) 4.9 Ending $ 74.0 $ 44.3 Intersegment sales and other operating revenue in our Logistics segment were $22.1 million and $28.9 million as of December 31, 2023 and 2022, respectively.
The increase in selling, general and administrative expense primarily reflects higher employee related expenses, higher cost of professional services, and transaction costs incurred as part of the granulated pig iron project.
These increases to sales and other operating revenue were partially offset by lower volumes and unfavorable pricing on our non-contracted blast coke sales. Selling, General and Administrative Expenses. The decrease in selling, general and administrative expense primarily reflects lower employee related expenses, lower cost of professional services and lower transaction costs incurred as part of the granulated pig iron project.
(2) Revenues increased primarily as a result of the pass-through of higher coal prices on our long-term, take-or-pay agreements, which also had a favorable impact on Adjusted EBITDA due to higher coal-to-coke yield gains on higher coal prices. Favorable pricing on export coke sales also increased revenues and was the primary driver of the increase to Adjusted EBITDA during 2022.
These higher volumes were mostly offset by lower volumes on non-contracted blast coke sales. (2) Revenues increased primarily as a result of the pass-through of higher coal prices on our long-term, take-or-pay agreements. Adjusted EBITDA decreased primarily due to lower margins on our non-contracted blast coke sales.
As of December 31, 2022 significant contractual obligations related to debt were $543.8 m illion of principal borrowings and $166.6 million of related interest, which will be repaid through 2029. Projected interest costs on variable rate instruments were calculated using market rates at December 31, 2022. See Note 11 to our consolidated financial statements.
As of December 31, 2023, significant contractual obligations related to debt were $500 m illion of principal borrowings and $134.1 million of related interest, which will be repaid through 2029. See Note 11 to our consolidated financial statements. We also have contractual obligations for leases, including land, office space, equipment, railcars and locomotives.
We may, from time to time, seek to retire or purchase additional amounts of our outstanding equity and/or debt securities through cash purchases and/or exchanges for other securities, in open market purchases, privately negotiated transactions or otherwise. Such repurchases or exchanges, if any, will depend on prevailing market conditions, our liquidity requirements, contractual restrictions and other factors.
As of December 31, 2023, we had $140.1 million of cash and cash equivalents and $350.0 million of borrowing availability under our Revolving Facility. 37 Table of Contents We may, from time to time, seek to retire or purchase additional amounts of our outstanding equity and/or debt securities through cash purchases and/or exchanges for other securities, in open market purchases, privately negotiated transactions or otherwise.
Market for Registrant’s Common Equity, Related Stockholders Matters and Issuer Purchases of Equity Securities." Covenants As of December 31, 2022, we were in compliance with all applicable debt covenants. We do not anticipate a violation of these covenants nor do we anticipate that any of these covenants will restrict our operations or our ability to obtain additional financing.
See further discussion in “Item 5. Market for Registrant’s Common Equity, Related Stockholders Matters and Issuer Purchases of Equity Securities.” Covenants As of December 31, 2023, we were in compliance with all applicable debt covenants.
A decrease of 25 basis points in the discount rate would have increased black lung expense by $1.1 million in 2022.
A decrease of 25 basis points in the discount rate would have increased black lung expense by $1.4 million in 2023. (2) The current portion of the black lung liability was $5.0 million and $5.9 million at December 31, 2023 and 2022, respectively, and was included in accrued liabilities on the Consolidated Balance Sheets.
We also have contractual obligations for leases, including land, office space, equipment, railcars and locomotives. See Note 13 to our consolidated financial statements. Capital Requirements and Expenditures Our operations are capital intensive, requiring significant investment to upgrade or enhance existing operations and to meet environmental and operational regulations.
See Note 13 to our consolidated financial statements. Capital Requirements and Expenditures Our operations are capital intensive, requiring significant investment to upgrade or enhance existing operations and to meet environmental and operational regulations. The level of future capital expenditures will depend on various factors, including market conditions and customer requirements, and may differ from current or anticipated levels.
See Note 11 to the consolidated financial statements for details on debt covenants. Credit Rating In May 2022, S&P Global Ratings reaffirmed our corporate credit rating of BB- (stable). In June 2022, Moody’s Investors Service reaffirmed our corporate credit rating of B1 and upgraded the outlook from stable to positive.
We do not anticipate a violation of these covenants nor do we anticipate that any of these covenants will restrict our operations or our ability to obtain additional financing. See Note 11 to our consolidated financial statements for details on debt covenants. Credit Rating In May 2023, S&P Global Ratings reaffirmed our corporate credit rating of BB- (stable).
Additionally, dividends paid in 2022 increased $3.5 million as compared to the dividends paid in the prior year as a result of an increase in the dividend per share amount.
This decrease was offset by an increase in dividends paid of $7.1 million as compared to the prior year period, primarily as a result of an increase in the dividend per share amount, as well as higher cash distributions made to noncontrolling interests of $7.4 million in the current year period.
See "Analysis of Segment Results" later in this section for further details of these results.
Consolidated Results of Operations The following section includes year-over-year analysis of consolidated results of operations for the year ended December 31, 2023 as compared to the year ended December 31, 2022. See “Analysis of Segment Results” later in this Item 7 for further details of these results.
Income tax expense during 2022 reflects the net impact of Foreign Tax Credit regulations signed in 2022 further described in Note 4 to our consolidated financial statements, which had a net result of an income tax benefit of $6.5 million during the current year period.
The current year period was further impacted by an increase in deferred income tax expense relating to new regulations impacting foreign tax credit utilization. See Note 4 to our consolidated financial statements for further detail on the change in deferred income tax expense.
Cash Used in Investing Activities Net cash used in investing activities decreased $29.1 million to $70.2 million in 2022 as compared to 2021 primarily driven by the timing of payments related to capital expenditures as well as the completion of certain foundry cokemaking expansion projects in 2021. Refer to Capital Requirements and Expenditures below for further detail.
Refer to Capital Requirements and Expenditures below for further detail. Cash Used in Financing Activities Net cash used in financing activities decreased $22.8 million to $89.7 million in 2023 as compared to $112.5 million in 202 2.
(2) Revenues and Adjusted EBITDA increased as a result of favorable pricing at CMT driven by the strong export coal market. (3) Other decreases in Adjusted EBITDA reflect higher operating and maintenance costs. Brazil Coke Sales and other operating revenue increased $1.4 million, or 4 percent, to $38.0 million in 2022 compared to $36.6 million in 2021.
Brazil Coke Sales and other operating revenue decreased $2.8 million, or 7 percent, to $35.2 million in 2023 compared to $38.0 million in 2022. Adjusted EBITDA decreased $5.4 million, or 37 percent, to $9.1 million in 2023 compared to $14.5 million 36 Table of Contents in 2022.
Lake Terminal and DRT are located adjacent to our Indiana Harbor and Jewell cokemaking facilities, respectively. The operations of each of our segments are described in Part I of this document. Corporate expenses that can be identified with a segment have been included in determining segment results. The remainder is included in Corporate and Other.
The DRT results were included in the Logistics segment in 2022 and are not recast. Corporate expenses that can be identified with a segment have been included in determining segment results.
Interest Expen se, net. Interest expense, net, benefited in 2022 from a lower interest rate on the outstanding senior notes, which decreased to 4.875 percent from 7.500 percent as a result of the debt refinancing that occurred during the second quarter of 2021, as well as lower average debt balances during the current year period. Income Tax Expense.
Interest expense, net, benefited in 2023 from lower average debt balances during the current year period and higher interest income of $2.0 million. Income Tax Expense.